Larvol Delta - XXL_202201-Study-Comparing-RT-With-Cetuximab--Xevinapant-to-RT-With-Cetuximabplacebo-in-Patients-With-Head-and-Neck-Cancer

Erbitux (cetuximab) - Eli Lilly

xevinapant (Debio 1143) - EMD Serono

cisplatin - Generic mfg.

http://clinicaltrials.gov/ct2/show/NCT05930938

May 9, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next